Andera Partners

Venture capital firm

Andera Partners is a Paris, France-based venture capital firm. Value Add VC tracks 2 companies Andera Partners has invested in and 2 venture rounds it took part in (1 as lead).

Andera Partners key facts (as of )

FactValueSource
HeadquartersParis, FranceSEC Form ADV (IAPD), October 18, 2026
TypeVenture capital firmValue Add VC classification
Venture rounds tracked2 (led 1, joined 1)
2 in the last 12 months
Recent deals table on this page (each round cites its source)
Portfolio companies tracked2Portfolio list on this page

Recent deals we track

2

Track record: led 1 and participated in 1 of 2 tracked venture rounds · 2 in the last 12 months · led 1 Growth

DateCompanyEventRoleAmountValuationInvestorsSource
Oct 19, 2026NouscomSeries DParticipated€120M—
M Ventures (Merck KGaA)LeadStartup Ticker · unverifiedEuropean Investment BankStartup Ticker · unverified5AM VenturesStartup Ticker · unverifiedAndera PartnersStartup Ticker · unverifiedBpifranceStartup Ticker · unverifiedVersant VenturesStartup Ticker · unverifiedRevelation PartnersAngelini IndustriesNeva SGRAngelini Ventures+5 more
EU-Startups
Sep 22, 2026HighLifeGrowthLed$90M—Pulse story

Is something wrong on this page?

We track Andera Partners but have little verified detail yet.

At a glance

Andera Partners appears in 2 funding rounds tracked by ValueAddVC since 2026, leading 1. Its most recent tracked deal was Nouscom's €120M Series D round (Oct 19, 2026).

Strategy

Geographies
Paris, France

Portfolio

2 total

Sector / Stage Activity

By stage (tracked rounds)
Series D
1 · 50%
Growth
1 · 50%

Co-Investors

4

Latest Pulse

  1. Nouscom Raises $135M To Push Cancer-Prevention Vaccine Toward ApprovalSwiss biotech Nouscom raised $135M (€120M) in a Series D co-led by M Ventures, Merck KGaA's venture arm, and Revelation Partners, to fund a global trial of cancer-prevention vaccine NOUS-209 in Lynch syndrome carriers.→
  2. HighLife Raises $90M For US Heart Valve StudyHighLife raised more than $90 million co-led by Andera Partners and Sofinnova Partners to fund a US pivotal study of its transcatheter mitral valve system and accelerate its European commercial rollout.→
  3. Cyllene Therapeutics Raises €33M for Gene TherapyCyllene Therapeutics, formerly EG 427, raised €33 million co-led by Merck Ventures to advance its HSV-1 gene-therapy platform toward treating neurogenic bladder conditions.→

Andera Partners FAQ

What stage does Andera Partners invest at?

In the rounds Value Add VC tracks, Andera Partners' deals were most often Series D (1) and Growth (1); it led 1 Growth.

What companies has Andera Partners backed?

Companies Value Add VC tracks as Andera Partners investments include Nouscom and HighLife.

Where is Andera Partners based?

Andera Partners is headquartered in Paris, France, according to SEC Form ADV (IAPD).

Who does Andera Partners co-invest with most?

In the rounds Value Add tracks, Andera Partners most often invests alongside 5AM Ventures (1 shared deal), Bpifrance (1 shared deal), M Ventures (Merck KGaA) (1 shared deal), Sectoral Asset Management (1 shared deal).

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data ·